 Polymerase chain reaction evidence human immunodeficiency virus neutralization passive immunization patients AIDS AIDS-related complex long-term safety potential efficacy passive immunization AIDS-related-complex ARC AIDS patients hyperimmune plasma healthy human immunodeficiency virus individuals cell-free virus circulation polymerase chain reaction PCR able conclusive evidence hyperimmune plasma effective long-term neutralization viremia cell test patients total antibody level ARC patients level years cell count AIDS patients stable ARC patient initial improvement patients advanced/terminal AIDS patients month studies passive immunization safe ARC AIDS patients viremia levels undetectable PCR advanced/terminal patients benefit limited duration ARC patients long-term passive immunization early disease